Oxidative stress and epigenetic mortality risk score: associations with all-cause mortality among elderly people

[1]  H. Brenner,et al.  Leukocyte telomere length and epigenetic-based mortality risk score: associations with all-cause mortality among older adults , 2018, Epigenetics.

[2]  H. Brenner,et al.  Vitamin D status and epigenetic-based mortality risk score: strong independent and joint prediction of all-cause mortality in a population-based cohort study , 2018, Clinical Epigenetics.

[3]  H. Brenner,et al.  Methylomic survival predictors, frailty, and mortality , 2018, Aging.

[4]  T. Hansen,et al.  Cardiovascular and All-Cause Mortality Risk Associated With Urinary Excretion of 8-oxoGuo, a Biomarker for RNA Oxidation, in Patients With Type 2 Diabetes: A Prospective Cohort Study , 2017, Diabetes Care.

[5]  H. Brenner,et al.  Associations of self-reported smoking, cotinine levels and epigenetic smoking indicators with oxidative stress among older adults: a population-based study , 2017, European Journal of Epidemiology.

[6]  Jonathan A. Heiss,et al.  DNA methylation signatures in peripheral blood strongly predict all-cause mortality , 2017, Nature Communications.

[7]  Johan Sundström,et al.  Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies , 2017, Circulation. Cardiovascular genetics.

[8]  S. Moreno,et al.  Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients , 2016, PloS one.

[9]  H. Brenner,et al.  Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data , 2015, BMC Medicine.

[10]  H. Brenner,et al.  Smoking-Associated DNA Methylation Biomarkers and Their Predictive Value for All-Cause and Cardiovascular Mortality , 2015, Environmental health perspectives.

[11]  H. Brenner,et al.  Oxidative stress markers and all-cause mortality at older age: a population-based cohort study. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  Thomas Mikeska,et al.  DNA Methylation Biomarkers: Cancer and Beyond , 2014, Genes.

[13]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[14]  E. Dermitzakis,et al.  Passive and active DNA methylation and the interplay with genetic variation in gene regulation , 2013, eLife.

[15]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[16]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[17]  A. Salminen,et al.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases , 2012, Cellular and Molecular Life Sciences.

[18]  M. Pencina,et al.  On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.

[19]  François Mariotti,et al.  Dose‐response analyses using restricted cubic spline functions in public health research , 2010, Statistics in medicine.

[20]  A. Salmon,et al.  Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging? , 2010, Free radical biology & medicine.

[21]  C. Maxia,et al.  Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma. , 2009, Oncology reports.

[22]  A. Valavanidis,et al.  8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis , 2009, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[23]  K. Kostikas,et al.  VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. , 2009, Lung cancer.

[24]  S. Bain,et al.  The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. , 2009, Atherosclerosis.

[25]  Christoph Plass,et al.  Lung cancer epigenetics and genetics , 2008, International journal of cancer.

[26]  P. Deininger,et al.  8‐Hydroxy‐2′‐deoxyguanosine (8‐OH‐dG) as a potential survival biomarker in patients with nonsmall‐cell lung cancer , 2007, Cancer.

[27]  V. Kinnula,et al.  8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD , 2006, European Respiratory Journal.

[28]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[29]  N. Lazzeri,et al.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. , 2000, American journal of respiratory and critical care medicine.

[30]  J. Schwartz,et al.  Cigarette smoking and peripheral blood leukocyte differentials. , 1994, Annals of epidemiology.